Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.
Ann Intern Med. 2012 Feb 21;156(4):263-70. doi: 10.7326/0003-4819-156-4-201202210-00378. Epub 2011 Nov 4.
Ann Intern Med. 2012.
PMID: 22056542
Free PMC article.
Community-based hepatitis B screening programs in the United States in 2008.
Rein DB, Lesesne SB, Leese PJ, Weinbaum CM.
Rein DB, et al. Among authors: lesesne sb.
J Viral Hepat. 2010 Jan;17(1):28-33. doi: 10.1111/j.1365-2893.2009.01165.x. Epub 2009 Aug 6.
J Viral Hepat. 2010.
PMID: 19674286
Item in Clipboard
Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008.
Rein DB, Lesesne SB, O'Fallon A, Weinbaum CM.
Rein DB, et al. Among authors: lesesne sb.
Hepatology. 2010 Feb;51(2):431-4. doi: 10.1002/hep.23353.
Hepatology. 2010.
PMID: 19902482
Item in Clipboard
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.
Rein DB, Wittenborn JS, Weinbaum CM, Sabin M, Smith BD, Lesesne SB.
Rein DB, et al. Among authors: lesesne sb.
Dig Liver Dis. 2011 Jan;43(1):66-72. doi: 10.1016/j.dld.2010.05.006. Epub 2010 Jun 17.
Dig Liver Dis. 2011.
PMID: 20739252
Item in Clipboard
Models of community-based hepatitis B surface antigen screening programs in the U.S. and their estimated outcomes and costs.
Rein DB, Lesesne SB, Smith BD, Weinbaum CM.
Rein DB, et al. Among authors: lesesne sb.
Public Health Rep. 2011 Jul-Aug;126(4):560-7. doi: 10.1177/003335491112600412.
Public Health Rep. 2011.
PMID: 21800750
Free PMC article.
Item in Clipboard
Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.
Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J; Vision Health Cost-Effectiveness Study Group.
Rein DB, et al. Among authors: lesesne sb.
Arch Ophthalmol. 2009 Apr;127(4):533-40. doi: 10.1001/archophthalmol.2009.58.
Arch Ophthalmol. 2009.
PMID: 19365036
Item in Clipboard
Cite
Cite